- Improving Concussion Awareness$1,455 RaisedSports-related concussions are often missed or disregarded in young athletes. Competitive pressures may drive children to continue playing after having a concussion. Delayed recognition can cause serious neurological problems including chronic headaches, memory lapses, learning difficulties, and even permanent disability if two or more concussions occur in close succession. Dr. James Noble, of Columbia University, plans to create an interactive educational activity to improve concussion awareness and reduce long-term brain damage in young athletes.
- Reducing Pain in Breast Cancer Treatment$885 RaisedMore than 40,000 women will die of breast cancer this year. Many of the most effective chemotherapy drugs for treating breast cancer cause serious side effects, including peripheral neuropathy, which causes numbness, pain and difficulty walking. Neuropathy is one of the most common reasons for stopping chemotherapy, potentially reducing the success of treatment. Neuropathy often drastically reduces quality of life. Drs. Gordon Smith, Kelsey Juster-Switlyk and Summer Karafiath of the University of Utah plan to find out what causes neuropathy, so that we can prevent it and get patients the treatment they need and improve their quality of life.
- EndedDetection of Brain Swelling$8,420 RaisedBrain swelling is a potentially lethal complication of acute brain injuries. Current methods of detecting brain swelling are invasive, or may identify its progression too late to reverse further damage. Dr. Charlene Ong of Harvard University will test whether an innovative handheld technology that measures pupil changes can improve the diagnosis and treatment of brain swelling. Her findings could save lives and improve quality of life for those who suffer from sudden and catastrophic brain injuries.
- A New Approach to Treating Dementia$13,335 RaisedAlzheimer’s disease and other neurodegenerative disorders including Frontotemporal dementia (FTD), Dementia with Lewy bodies(DLB), Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and progressive supranuclear palsy (PSP) are some of the most devastating afflictions faced by individuals, their families, and our society. There is no cure available for these neurodegenerative conditions. Dr. Werner and his team at Cogentis Therapeutics are developing groundbreaking therapies to reverse these disorders in collaboration with the NIH, Harvard Medical School, MIT, and Johns Hopkins University.